MORGAN STANLEY PLC/CALL/BRISTOL-MYERS SQUIBB/68/0.1/20.09.24 Stock MORGAN STANLEY PLC/CALL/BRISTOL-MYERS SQUIBB/68/0.1/20.09.24
Add to a list
To use this feature you must be a member
Log inSign up

MORGAN STANLEY PLC/CALL/BRISTOL-MYERS SQUIBB/68/0.1/20.09.24 Share Price

Warrant

DE000ME48BF8

Market Closed - Börse Stuttgart 17:55:01 28/06/2024 BST
0.018 EUR 0.00% Intraday chart for MORGAN STANLEY PLC/CALL/BRISTOL-MYERS SQUIBB/68/0.1/20.09.24
Current month+63.64%
1 month+50.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Chart BRISTOL-MYERS SQUIBB COMPANY
Chart MORGAN STANLEY PLC/CALL/BRISTOL-MYERS SQUIBB/68/0.1/20.09.24

Latest news about BRISTOL-MYERS SQUIBB COMPANY

Purple Biotech Says Interim Data from Pancreatic Cancer Drug Study Shows Promise MT
2seventy bio Sells Hemophilia A Candidate, Gene Editing Technology to Novo Nordisk; Shares Rise After Hours MT
Top Midday Stories: Southwest Cuts Q2 Guidance; HHS to Lower Costs for Medicare Enrollees on 64 Drugs; Bosch Weighing Acquisition Offer for Whirlpool; Novo Nordisk to Record $816.2 Million Impairment MT
Biden Administration to Lower Costs for 64 Prescription Drugs for Medicare Enrollees MT
More news

Quotes 5-day view

Date Price Change
28/06/24 0.018 0.00%
27/06/24 0.018 0.00%
26/06/24 0.018 +5.88%
25/06/24 0.017 0.00%
24/06/24 0.017 +21.43%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 05:55 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying BRISTOL-MYERS SQUIBB COMPANY
Issuer Morgan Stanley
WKN ME48BF
ISINDE000ME48BF8
Date issued 28/11/2023
Strike 68 $
Maturity 20/09/2024 (83 Days)
Parity 10 : 1
Emission price 0.09 €
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.079 €
Lowest since issue 0.007 €
Delta0.06x
Omega 8.767
Premium62.65x
Gearing137.52x
Moneyness 0.6176
Difference Strike 26.47 $
Difference Strike %+38.93%
Spread 0.023 €
Spread %57.50%
Theoretical value 0.0285
Implied Volatility 60.63 %
Total Loss Probability 96.48 %
Intrinsic value 0.000000
Present value 0.0285
Break even 68.31 €
Theta-0.01x
Vega0x
Rho0x

Company Profile

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 70.1% of net sales.
Sector
-
More about the company

Ratings for Bristol-Myers Squibb Company

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Bristol-Myers Squibb Company

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.53 USD
Average target price
53.19 USD
Spread / Average Target
+28.09%
Consensus
  1. Stock Market
  2. Warrants
  3. Warrant